Issue 43, 2024

A simple hydrogen peroxide-activatable Bodipy for tumor imaging and type I/II photodynamic therapy

Abstract

Tumor microenvironment-activatable photosensitizers have gained significant attention for cancer theranostics. Considering the hypoxic environment of solid tumors, activatable phototheranostic agents with type I PDT are desired to obtain improved cancer treatment efficiency. Herein, we report a simple, effective and multifunctional Bodipy photosensitizer for tumor imaging and type I/II photodynamic therapy. The photosensitizer featuring a methylphenylboronic acid pinacol ester group at the meso-position of Bodipy specifically responds to tumor-abundant H2O2. Its photophysical properties were characterized using steady-state and time-resolved transient optical spectroscopies. The fluorescence (ΦF = 0.09%) and singlet oxygen efficacy (ΦΔ = 10.2%) of the Bodipy units were suppressed in the caged dyads but significantly enhanced (ΦF = 0.72%, ΦΔ = 20.3%) upon H2O2 activation. Fluorescence emission spectroscopy and continuous wave electron paramagnetic resonance (EPR) spectroscopy confirmed that the Bodipy photosensitizer generates reactive oxygen species (ROS) via both electron transfer-mediated type I and energy transfer-mediated type II mechanisms. In vitro experiments demonstrated rapid internalization into tumor cells, enhanced brightness stimulated by tumor microenvironments, and tumor cell death (phototoxicity, IC50 = 0.5 μM). In vivo fluorescence imaging indicated preferential accumulation of this Bodipy photosensitizer in tumor sites, followed by decaging by tumor-abundant H2O2, further elevating the signal-to-background ratio (SBR) of imaging. Besides outstanding performance in tumor imaging, a prominent inhibition of tumor growth was observed. Given its simple molecular skeleton, this Bodipy photosensitizer is a competitive candidate for cancer theranostics.

Graphical abstract: A simple hydrogen peroxide-activatable Bodipy for tumor imaging and type I/II photodynamic therapy

Supplementary files

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Paper
Submitted
27 Jul 2024
Accepted
25 Sep 2024
First published
26 Sep 2024

J. Mater. Chem. B, 2024,12, 11165-11171

A simple hydrogen peroxide-activatable Bodipy for tumor imaging and type I/II photodynamic therapy

F. Ge, Y. Sun, Y. Wang, D. Yu, Z. Wang, F. Yu, B. Yu and H. Fu, J. Mater. Chem. B, 2024, 12, 11165 DOI: 10.1039/D4TB01650E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements